Association of Wearable Device Use With Pulse Rate and Health Care Use in Adults With Atrial Fibrillation

EN BREF ...

"Commercially available wearable devices (hereafter wearables) have flooded the market in recent years.Wearables are often marketed as health and wellness devices, with smartwatches and wristbands leading the wearable technology space. Hardware and software improvements have enabled additional features, such as heart rate monitoring, sleep monitoring, pulse oximetry, and respiration tracking. These advances open up new possibilities for disease-specific screening and management.Several devices cleared by the Food and Drug Administration (FDA) (eg, Apple Watch4 and AliveCor Kardia Band5) allow individuals to generate a single lead electrocardiogram (ECG) to screen for arrhythmias, such as atrial fibrillation (AF). Studies from 2019, and 2020 found that such devices were reasonably sensitive and specific in diagnosing new-onset AF, albeit among populations with high disease prevalence. The FDA recently reorganized the Center for Device and Radiological Health to reduce burdensome premarket approval processes. This is likely to increase the number of wearables available on the market." En bref issu de l'étude.